|
Volumn 56, Issue 2, 2008, Pages 227-230
|
Determination of (R)-xanthoanthrafil, a phosphodiesterase-5 inhibitor, in a dietary supplement promoted for sexual enhancement
|
Author keywords
HPLC; Liquid chromatography mass spectrometry; NMR; Penile erectile dysfunction; TLC; Xanthoanthrafil
|
Indexed keywords
BENZAMIDE DERIVATIVE;
FR 226807;
N (3,4 DIMETHOXYBENZYL) 2 (1 HYDROXYPROPAN 2 YLAMINO) 5 NITROBENZAMIDE;
PHOSPHODIESTERASE V INHIBITOR;
UNCLASSIFIED DRUG;
XANTHOANTHRAFIL;
ARTICLE;
DIET SUPPLEMENTATION;
DRUG RETENTION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MOLECULAR WEIGHT;
NUCLEAR MAGNETIC RESONANCE;
OPTICAL ROTATION;
QUANTITATIVE ANALYSIS;
SEXUAL FUNCTION;
THIN LAYER CHROMATOGRAPHY;
BENZAMIDES;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CHROMATOGRAPHY, THIN LAYER;
CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5;
DIETARY SUPPLEMENTS;
INDICATORS AND REAGENTS;
MAGNETIC RESONANCE SPECTROSCOPY;
MASS SPECTROMETRY;
MODELS, MOLECULAR;
MOLECULAR CONFORMATION;
PHOSPHODIESTERASE INHIBITORS;
STREET DRUGS;
|
EID: 38849202604
PISSN: 00092363
EISSN: 13475223
Source Type: Journal
DOI: 10.1248/cpb.56.227 Document Type: Article |
Times cited : (20)
|
References (12)
|